Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication September 6, 2018
- Accepted for publication November 1, 2018
- Published online June 3, 2019.
Article Versions
- previous version (November 15, 2018 - 13:03).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Louise Emmett1,
- Ur Metser2,
- Glenn Bauman3,
- Rodney J. Hicks4,
- Andrew Weickhardt5,
- Ian D. Davis6,
- Shonit Punwani7,
- Greg Pond8,
- Sue Chua9,
- Bao Ho1,
- Edward Johnston7,
- Frederic Pouliot10 and
- Andrew M. Scott5
- 1St. Vincent’s Hospital, Sydney, New South Wales, Australia
- 2University of Toronto, Toronto, Ontario, Canada
- 3London Health Sciences Centre, London, Ontario, Canada
- 4Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
- 5Olivia Newton-John Cancer Research Institute, La Trobe University, Melbourne, Australia and Austin Health, University of Melbourne, Melbourne, Australia
- 6Monash University Eastern Health Clinical School, Box Hill, Victoria, Australia
- 7University College London, London, United Kingdom
- 8McMaster University, Hamilton, Ontario, Canada
- 9Royal Marsden Hospital, London, United Kingdom; and
- 10CHU de Quebec and Université Laval, Quebec, Quebec, Canada
- For correspondence or reprints contact: Louise Emmett, Department of Theranostics, St. Vincent’s Hospital, Sydney, New South Wales, Australia. E-mail: louise.emmett{at}svha.org.au
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT
- A 2022 International Survey on the Status of Prostate Cancer Theranostics
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
- PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
- 3-Year Freedom from Progression After 68Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial